Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

Online
ISSN
1437-4331
See all formats and pricing
Volume 45, Issue 6 (Jun 2007)

Issues

Blood gas and patient safety: considerations based on experience developed in accordance with the Risk Management perspective

Marco Rambaldi
  • 1U.O. Anestesia e Rianimazione, Azienda Sanitaria di Modena, Modena, Italy
/ MariaTeresa Baranzoni
  • 2U.O. Anestesia e Rianimazione, Azienda Sanitaria di Modena, Modena, Italy
/ Pasquale Coppolecchia
  • 3Laboratorio Analisi, Azienda Sanitaria di Modena, Modena, Italy
/ Jennifer N. Moschello
  • 4Servizio Ingegneria Clinica, Azienda Sanitaria di Modena, Modena, Italy
/ Francesca Novaco
  • 5Sistema Qualità Aziendale, Azienda Sanitaria di Modena, Modena, Italy
Published Online: 2007-06-19 | DOI: https://doi.org/10.1515/CCLM.2007.163

Abstract

It is the responsibility of health organizations to guarantee a high level of healthcare by using adequate methodologies and instruments, creating secure conditions for treatment, and preventing adverse events due to human or system errors. It is necessary to introduce Risk Management programs, and in particular to promote Clinical Risk Management, one of the constituent elements of Clinical Governance, to assure the delivery of high-quality performance and services. In the point-of-care testing (POCT) context, using an analysis of our experiences, we discuss the entire analytical process, including acquisition and usage, while focusing on blood gas analyzers. Our experience confirms that within a Clinical Governance framework, it is necessary to apply, even when choosing instruments, a systematic vision that is not limited to analytical validation, but also includes an in-depth analysis of the impact in a specific context. Assessment of the correlated risks, independent of the analytical methodology used, is indispensable in a clinical environment to identify the most suitable approach for such risks. A study of the latent factors can be proactively performed to identify (and stimulate) what the pre-organizational environment (producer companies) can offer in terms of product orientation to effectively reduce correlated risk during use. Among the different options for possible treatment of risk, one involves the transfer of the assumption of risk to third parties (e.g., maintenance and quality controls). Transferring the responsibility for control operations to the operator of the instrument, which follows the quality controls with total autonomy, is equivalent to transferring the correlated risk for the clinician (in the POCT case) to the producer, who becomes the guarantor. In practice this is equivalent to a specific assurance stipulation with zero cost.

Clin Chem Lab Med 2007;45:774–80.

Keywords: blood gas; clinical risk management; patient safety; point-of-care testing

About the article

Corresponding author: Dr. Marco Rambaldi, Ospedale Nuovo S. Agostino Estense, Responsabile U.O. Anestesia e Rianimazione, Via Giardini 1355, 41100 Modena, Italy Phone: +39-059-3961111, Fax: +39-059-437269,


Published Online: 2007-06-19

Published in Print: 2007-06-01


Citation Information: Clinical Chemical Laboratory Medicine, ISSN (Online) 14374331, ISSN (Print) 14346621, DOI: https://doi.org/10.1515/CCLM.2007.163. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Pirjo Hedberg, Aila Majava, Kai Kiviluoma, and Pasi Ohtonen
Scandinavian Journal of Clinical and Laboratory Investigation, 2009, Volume 69, Number 5, Page 585
[2]
Mario Plebani
Clinical Chemistry and Laboratory Medicine, 2013, Volume 51, Number 1
[3]
Barbara Roda, Andrea Zattoni, Pierluigi Reschiglian, Myeong Hee Moon, Mara Mirasoli, Elisa Michelini, and Aldo Roda
Analytica Chimica Acta, 2009, Volume 635, Number 2, Page 132
[4]
R. Pretagostini, F. Gabbrielli, P. Fiaschetti, A. Oliveti, S. Cenci, D. Peritore, and D. Stabile
Transplantation Proceedings, 2010, Volume 42, Number 4, Page 1014

Comments (0)

Please log in or register to comment.
Log in